Why Iovance Biotherapeutics Inc (NASDAQ: IOVA) Is A Stock Not To Be Discarded In 2025
In today’s recent session, 2.51 million shares of the Iovance Biotherapeutics Inc (NASDAQ:IOVA) have been traded, and its beta is 1.07. Most recently the company’s